By acquiring Biovex, we're continuing the transformation of Amgen into a company that supports therapeutic oncology as well as supportive care oncology. — Roger M. Perlmutter Copy Share Image
By acquiring Biovex, we're continuing the transformation of Amgen into a company that supports therapeutic oncology as well as supportive care oncology. — Roger M. Perlmutter Copy Share Image
Throughout my career, as both a physician and a scientist, I have drawn inspiration from Merck's unwavering commitment to scientific excellence. Over time, this… — Roger M. Perlmutter Copy Share Image
